Patent 10894012 was granted and assigned to Genus Lifesciences Inc. on January, 2021 by the United States Patent and Trademark Office.
Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.